Hyperinsulinemic hypoglycemia of the neonate associated with persistent fetal histology and function of the pancreas.
Early in development, the fetal pancreas is characterized by the presence of two distinct generations of endocrine cells  and a B-Cell mass that is unresponsive to acute changes in circulating glucose levels. Near the end of intrauterine development, the normal pancreas has "matured" and contains a single generation of endocrine cells and B-Cells that are responsive to changes in glucose concentrations. Recent microscopic examination of resected pancreatic tissue from an infant with hyperinsulinemic hypoglycermia revealed a combination of all three of the currently accepted findings in this neonatal condition: hyperplasia, adenomatosis, and nesidioblastosis. These observations prompted the following hypothesis: When compared to the usual histology of the developing pancreas, nesidioblastosis may be interpreted as an abnormal continuation of normal proliferation of endocrine cells; hyperplasia may be a specific overproduction of the Secondary Islands of Langerhans; and adenomatosis may be an abnormal continuation or overgrowth of the Primary Island of Langerhans. Such extrapolation suggests that infants with hyperinsulinemic hypoglycemia may represent a failure in the normal histological and functional maturation of the endocrine portion of the fetal pancreas.
D000236:Adenoma / Q000473:pathology; D007516:Adenoma, Islet Cell / Q000473:pathology; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications / Q000209:etiology* / Q000473:pathology; D006965:Hyperplasia; D007003:Hypoglycemia / Q000150:complications / Q000209:etiology* / Q000473:pathology; D007231:Infant, Newborn; D007515:Islets of Langerhans / Q000473:pathology / Q000503:physiopathology*; D008407:Mast Cells; D010179:Pancreas / Q000196:embryology*; D010190:Pancreatic Neoplasms / Q000473:pathology; D011247:Pregnancy
D001786:Blood Glucose